Habboush Yacob, Guzman Nilmarie
Orange Park Medical Center
Recognition of issues related to the use of antibiotics has been present since their early clinical introduction in the 1940s. Since then, the use of antimicrobials and often inappropriate use of these have been increasing. Antibiotic resistance in the United States kills approximately 23,000 patients a year and incurs over $20 billion in additional medical expenses. Antibiotic stewardship was established to combat this trend and was recognized in 1996 to draw attention to the rising incidents in mortality and morbidity associated with inappropriate use of antibiotics. Antimicrobial agents are at least partially responsible for the development of serious infections, such as Staphylococcus aureus, vancomycin-resistant enterococci, extended-spectrum B-lactamase producing Enterobacteriaceae, and other infectious agents. The focus of the stewardship programs is to improve clinical outcomes, decrease antibiotic resistance, and decrease healthcare costs. In 2007, stewardship programs were nationally recognized and reinforced by the publication of the stewardship guidelines from the Infectious Disease Society of America (IDSA) in association with the Society of Healthcare Epidemiology of America (SHEA). These guidelines were helpful in developing an institutional program to enhance antimicrobial stewardship. Antibiotics are powerful drugs that are used to combat once fatal diseases. As with any powerful medication, antibiotics carry a wide range of adverse effects. The appropriate use of such agents has a high beneficiary effect that outweighs the risks. However, once antibiotics are unnecessarily used, patients experience no benefits while their susceptibility to the side effects is still present. Moreover, antibiotics disrupt the composition of the infectious agent, leading to bacterial adaptation or mutations, and in turn, to new strains that are resistant to the current antibiotic regimen. The inappropriate use of antibiotics in one patient might develop a resistant strain that spreads to other patients that do not use antibiotics, which makes this issue a pressing public health problem. In 2015, 30% of the outpatient antibiotics prescribed were unnecessary, with acute respiratory infections holding the highest unnecessary use of antibiotics at 50%.
自20世纪40年代抗生素早期临床应用以来,人们就已经认识到与抗生素使用相关的问题。从那时起,抗菌药物的使用以及这些药物的不当使用一直在增加。在美国,抗生素耐药性每年导致约23000名患者死亡,并产生超过200亿美元的额外医疗费用。抗生素管理应运而生,以应对这一趋势,并于1996年得到认可,以引起人们对与不当使用抗生素相关的死亡率和发病率上升事件的关注。抗菌药物至少部分导致了严重感染的发生,如金黄色葡萄球菌、耐万古霉素肠球菌、产超广谱β-内酰胺酶的肠杆菌科细菌以及其他感染病原体。管理计划的重点是改善临床结果、降低抗生素耐药性并降低医疗成本。2007年,美国传染病学会(IDSA)与美国医疗保健流行病学学会(SHEA)联合发布的管理指南使管理计划得到了全国认可和加强。这些指南有助于制定一个机构计划,以加强抗菌药物管理。抗生素是用于对抗曾经致命疾病的强效药物。与任何强效药物一样,抗生素有广泛的副作用。合理使用此类药物具有很高的受益效果,超过了风险。然而,一旦不必要地使用抗生素,患者既无益处,又仍易出现副作用。此外,抗生素会破坏感染病原体的组成,导致细菌适应或突变,进而产生对当前抗生素治疗方案耐药的新菌株。一名患者不当使用抗生素可能会产生耐药菌株,并传播给其他未使用抗生素的患者,这使得这个问题成为一个紧迫的公共卫生问题。2015年,门诊开出的抗生素中有30%是不必要的,急性呼吸道感染的抗生素不必要使用率最高,为50%。